1 |
Shulman ST. Pediatric autoimmune neuropsychiatric disorders associated with streptococci (PANDAS): Update. Curr Opin Pediatr 2009; 21:127.
DOI
ScienceOn
|
2 |
ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization;1992.
|
3 |
Nestadt G, Samuels J, Riddle M, Bienvenu III OJ, Liang KY, LaBuda M, et al. A family study of obsessive-compulsive disorder. Arch Gen Psychiatry 2000;57:358.
DOI
ScienceOn
|
4 |
Storch EA, Lack C, Merlo LJ, Marien WE, Geffken GR, Grabill K, et al. Associations between miscellaneous symptoms and symptom dimensions: an examination of pediatric obsessive-compulsive disorder. Behav Res Ther 2007;45:2593-2603.
DOI
ScienceOn
|
5 |
Wendland JR, Moya PR, Timpano KR, Anavitarte AP, Kruse MR, Wheaton MG, et al. A haplotype containing quantitative trait loci for SLC1A1 gene expression and its association with obsessive-compulsive disorder. Arch Gen Psychiatry 2009;66:408.
DOI
ScienceOn
|
6 |
McKay D, Neziroglu F. Methodological issues in the obsessive-compulsive spectrum. Psychiatry Res 2009;170:61-65.
DOI
ScienceOn
|
7 |
Lucey JV, Costa DC, Blanes T, Busatto GF, Pilowsky LS, Takei N, et al. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions. Br J Psychiatry 1995;167:629.
DOI
ScienceOn
|
8 |
Leckman JF, Kim Y. A primary candidate gene for obsessive-compulsive disorder. Arch Gen Psychiatry 2006;63:717-720.
DOI
ScienceOn
|
9 |
Chamberlain SR, Fineberg NA, Blackwell AD, Robbins TW, Sahakian BJ. Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania. Am J Psychiatry 2006;163:1282-1284.
DOI
ScienceOn
|
10 |
Bienvenu OJ, Samuels JF, Riddle MA, Hoehn-Saric R, Liang KY, Cullen BA, et al. The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study. Biol Psychiatry 2000;48:287-293.
DOI
ScienceOn
|
11 |
Rosario-Campos MC, Miguel EC, Quatrano S, Chacon P, Ferrao Y, Findley D, et al. The Dimensional Yale-Brown Obsessive-Compulsive Scale (DY-BOCS): an instrument for assessing obsessive-compulsive symptom dimensions. Mol Psychiatry 2006;11:495-504.
DOI
ScienceOn
|
12 |
Grados MA, Riddle MA, Samuels JF, Liang KY, Hoehn-Saric R, Bienvenu OJ, et al. The familial phenotype of obsessive-compulsive disorder in relation to tic disorders: the Hopkins OCD family study. Biol Psychiatry 2001;50:559-565.
DOI
ScienceOn
|
13 |
Kim SJ, Choi NK, Hong HJ, Hwang YS, Kim YK, Lee HS, et al. Dimensional Analyses of the Yale-Brown Obsessive-Compulsive Scale and Yale-Brown Obsessive-Compulsive Scale Checklist. Korean J Psycho-pharmacol 2004;15:339-345.
|
14 |
Pinto A, Greenberg BD, Grados MA, Bienvenu III OJ, Samuels JF, Murphy DL, et al. Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories. Psychiatry Res 2008;160:83-93.
DOI
ScienceOn
|
15 |
Storch EA, McNamara J, Jordan C, Marien WE, Jacob ML, Murphy TK, et al. Associations between miscellaneous symptoms and symptom dimensions in adults with obsessive-compulsive disorder. Anxiety Stress Coping 2008;21:199-212.
DOI
ScienceOn
|
16 |
Mataix-Cols D, do Rosario-Campos MC, Leckman JF. A multidimensional model of obsessive-compulsive disorder. Am J Psychiatry 2005; 162:228.
DOI
ScienceOn
|
17 |
Richter MA, Summerfeldt LJ, Antony MM, Swinson RP. Obsessivecompulsive spectrum conditions in obsessive compulsive disorder and other anxiety disorders. Depress Anxiety 2003;18:118-127.
DOI
ScienceOn
|
18 |
Hemmings SM, Kinnear CJ, Lochner C, Seedat S, Corfield VA, Moolman- Smook JC, et al. Genetic correlates in trichotillomania--A casecontrol association study in the South African Caucasian population. Isr J Psychiatry Relat Sci 2006;43:93.
|
19 |
Keuthen NJ, Makris N, Schlerf JE, Martis B, Savage CR, McMullin K, et al. Evidence for reduced cerebellar volumes in trichotillomania. Biol Psychiatry 2007;61:374-381.
DOI
ScienceOn
|
20 |
O'Sullivan RL, Rauch SL, Breiter HC, Grachev ID, Baer L, Kennedy DN, et al. Reduced basal ganglia volumes in trichotillomania measured via morphometric magnetic resonance imaging. Biol Psychiatry 1997;42:39-45.
DOI
ScienceOn
|
21 |
http://www.psych.org/MainMenu/Research/DSMIV/DSMV/DSMRevisionActivities/ ConferenceSummaries/ObsessiveCompulsiveSpectrumDisorders Conference.aspx.
|
22 |
Taylor S, Mckay D, Abramowitz JS, Woody EZ, Szechtman H. Comment on: Is obsessive-compulsive disorder a disturbance of security motivation? By Szechtman et al. Psychol Rev 2005;112:650-661.
DOI
|
23 |
Hollander E, Kim SJ, Braun A, Simeon D, Zohar J. Cross-cutting issues and future directions for the OCD spectrum. Psychiatry Res 2009; 170:3-6.
DOI
ScienceOn
|
24 |
Leckman JF, Bloch MH, King RA. Symptom dimensions and subtypes of obsessive-compulsive disorder: a developmental perspective. Dialogues Clin Neurosci 2009;11:21-33.
|
25 |
do Rosario-Campos MC, Leckman JF, Curi M, Quatrano S, Katsovitch L, Miguel EC, et al. A family study of early-onset obsessivecompulsive disorder. Am J Med Genet B Neuropsychiatr Genet 2005; 136:92-97.
|
26 |
Holzer JC, Goodman WK, McDougle CJ, Baer L, Boyarsky BK, Leckman JF, et al. Obsessive-compulsive disorder with and without a chronic tic disorder. A comparison of symptoms in 70 patients. Br J Psychiatry 1994;164:469-473.
DOI
ScienceOn
|
27 |
Phillips KA, Stein DJ, Rauch SL, Hollander E, Fallon BA, Barsky A, et al. Should an obsessive-compulsive spectrum grouping of disorders be included in DSM-V? Depress Anxiety 2010;27:528-555.
DOI
ScienceOn
|
28 |
Phillips KA, Hollander E. Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. Body Image 2008;5:13-27.
DOI
ScienceOn
|
29 |
Ipser JC, Sander C, Stein DJ. Pharmacotherapy and psychotherapy for body dysmorphic disorder. Cochrane Database Syst Rev 2009:CD-005332.
|
30 |
Neziroglu F, Khemlani-Patel S. A review of cognitive and behavioral treatment for body dysmorphic disorder. CNS Spectr 2002;7:464-471.
DOI
|
31 |
Saxena S, Feusner JD. Toward a neurobiology of body dysmorphic disorder. Prim psychiatry 2006;13:41.
|
32 |
Rotge J, Guehl D, Dilharreguy B, Cuny E, Tignol J, Bioulac B, et al. Provocation of obsessive-compulsive symptoms: a quantitative voxelbased meta-analysis of functional neuroimaging studies. J Psychiatry Neurosci 2008;33:405-412.
|
33 |
Deckersbach T, Savage CR, Phillips KA, Wilhelm S, Buhlmann U, Rauch SL, et al. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc 2000;6:673-681.
DOI
ScienceOn
|
34 |
Sherman BJ, Savage CR, Eddy KT, Blais MA, Deckersbach T, Jackson SC, et al. Strategic memory in adults with anorexia nervosa: are there similarities to obsessive compulsive spectrum disorders? Int J Eat Disord 2006;39:468-476.
DOI
ScienceOn
|
35 |
Jaisoorya TS, Janardhan R. The relationship of obsessive-compulsive disorder to putative spectrum disorders: results from an Indian study. Compr Psychiatry 2003;44:317-323.
DOI
ScienceOn
|
36 |
Miguel EC, Ferro YA, Rosario MC, de Mathis MA, Torres AR, Fontenelle LF, et al. The Brazilian Research Consortium on Obsessive- Compulsive Spectrum Disorders: recruitment, assessment instruments, methods for the development of multicenter collaborative studies and preliminary results. Rev BrasPsiquiatr Braz J Psychiatry 2008;30:185-196.
|
37 |
Fineberg NA, Gale TM. Evidence-based pharmacotherapy of obsessive- compulsive disorder. Int J Neuropsychopharmacol 2005;8:107-129.
DOI
ScienceOn
|
38 |
Stein DJ, Denys D, Gloster AT, Hollander E, Leckman JF, Rauch SL, et al. Obsessive-compulsive disorder: diagnostic and treatment issues. Psychiatr Clin North Am 2009;32:665-685.
DOI
ScienceOn
|
39 |
Arch J, Craske MG. First-line treatment: a critical appraisal of cognitive behavioral therapy developments and alternatives. Psychiatr Clin North Am 2009;32:525-547.
DOI
ScienceOn
|
40 |
Geffken GR, Storch EA, Gelfand KM, Adkins JW, Goodman WK. Cognitive-behavioral therapy for obsessive-compulsive disorder: review of treatment techniques. J Psychosoc Nurs Ment Health Serv 2004;42:44-51.
|
41 |
Mataix-Cols D, Pertusa A, Leckman JF. Issues for DSM-V: how should obsessive-compulsive and related disorders be classified? Am J Psychiatry 2007;164:1313-1314.
DOI
ScienceOn
|
42 |
McKay D, Abramowitz JS, Calamari JE, Kyrios M, Radomsky A, Sookman D, et al. A critical evaluation of obsessive-compulsive disorder subtypes: Symptoms versus mechanisms* 1. Clin Psychol Rev 2004;24:283-313.
DOI
ScienceOn
|
43 |
Stein DJ, Lochner C. Obsessive-compulsive spectrum disorders: a multidimensional approach. Psychiatr Clin North Am 2006;29:343-351.
DOI
ScienceOn
|
44 |
Joel D, Stein DJ, Schreiber R. Animal models of obsessive-compulsive disorder: from bench to bedside via endophenotypes and biomarkers. In: McArthur RA, Borsini F, editors. Animal and Translational Models for CNS Drug Discovery, Volume 1: Psychiatric Disorders. Amsterdam: Elsevier;2008.
|
45 |
Hollander E. Obsessive-compulsive related disorders: Amer Psychiatric Pub Inc;1993.
|
46 |
Phillips KA, McElroy SL, Keck PE, Pope HG, Hudson JI. Body dysmorphic disorder: 30 cases of imagined ugliness. Am J Psychiatry 1993; 150:302-308.
DOI
|
47 |
Stein DJ, Fineberg NA, Bienvenu OJ, Denys D, Lochner C, Nestadt G, et al. Should OCD be classified as an anxiety disorder in DSM-V? Depress Anxiety 2010;27:495-506.
DOI
ScienceOn
|
48 |
Rauch SL, Drevets WC. Neuroimaging and neuroanatomy of stressinduced and fear circuitry disorders. In: Andrews G, Charney DS, P.J. S, Regier DA, editors. Stress-Induced and Fear Circuitry Disorders: Refining the Research Agenda for DSM-V. Arlington, VA: American Psychiatric Association;2009.
|
49 |
Rauch SL, Wedig M, Wright CI, Martis B, McMullin KG, Shin LM, et al. Functional magnetic resonance imaging study of regional brain activation during implicit sequence learning in obsessive-compulsive disorder. Biol Psychiatry 2007;61:330-336.
DOI
ScienceOn
|
50 |
Fitzgerald KD, Welsh RC, Gehring WJ, Abelson JL, Himle JA, Liberzon I, et al. Error-related hyperactivity of the anterior cingulate cortex in obsessive-compulsive disorder. Biol Psychiatry 2005;57:287-294.
DOI
ScienceOn
|
51 |
Greenberg BD, Rauch SL, Haber SN. Invasive circuitry-based neurotherapeutics: stereotactic ablation and deep brain stimulation for OCD. Neuropsychopharmacology 2009;35:317-336.
|
52 |
Cannistraro PA, Wright CI, Wedig M, Martis B, Shin LM, Wilhelm S, et al. Amygdala responses to human faces in obsessive-compulsive disorder. Biol Psychiatry 2004;56:916-920.
DOI
ScienceOn
|
53 |
Menzies L, Achard S, Chamberlain SR, Fineberg N, Chen C, del Campo N, et al. Neurocognitive endophenotypes of obsessive-compulsive disorder. Brain 2007;130:3223-3236.
DOI
ScienceOn
|
54 |
Baldwin DS, Anderson IM, Nutt DJ, Bandelow B, Bond A, Davidson JR, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2005;19:567-596.
DOI
ScienceOn
|
55 |
Stein DJ, Ipser JC, Baldwin DS, Bandelow B. Treatment of obsessivecompulsive disorder. CNS Spectr 2007;12:28-35.
DOI
|
56 |
Baxter Jr LR, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. Arch Gen Psychiatry 1992;49:681.
DOI
ScienceOn
|
57 |
Hu XZ, Lipsky RH, Zhu G, Akhtar LA, Taubman J, Greenberg BD, et al. Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 2006;78:815-826.
DOI
ScienceOn
|
58 |
Kang DH, Kwon JS, Kim JJ, Youn T, Park HJ, Kim MS, et al. Brain glucose metabolic changes associated with neuropsychological improvements after 4 months of treatment in patients with obsessivecompulsive disorder. Acta Psychiatr Scand 2003;107:291-297.
DOI
ScienceOn
|
59 |
Alexander GE, Crutcher MD, DeLong MR. Basal ganglia-thalamocortical circuits: Parallel substrates for motor, oculomotor. Prog Brain Res 1991;85:119-146.
DOI
|
60 |
Cavallini MC, Di Bella D, Siliprandi F, Malchiodi F, Bellodi L. Exploratory factor analysis of obsessive-compulsive patients and association with 5-HTTLPR polymorphism. Am J Med Genet B Neuropsychiatr Genet 2002;114:347-353.
DOI
ScienceOn
|
61 |
Arnold PD, Rosenberg DR, Mundo E, Tharmalingam S, Kennedy JL, Richter MA. Association of a glutamate (NMDA) subunit receptor gene (GRIN2B) with obsessive-compulsive disorder: a preliminary study. Psychopharmacologia 2004;174:530-538.
|
62 |
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed., text revision ed. Washington, DC: American Psychiatric Press;2000.
|
63 |
ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization;1992.
|
64 |
Storch EA, Abramowitz J, Goodman WK. Where does obsessive-compulsive disorder belong in DSM-V? Depress Anxiety 2008;25:336-347.
DOI
ScienceOn
|
65 |
Hollander E, Braun A, Simeon D. Should OCD leave the anxiety disorders in DSM-V? The case for obsessive compulsive-related disorders. Depress Anxiety 2008;25:317-329.
DOI
ScienceOn
|
66 |
Hollander E, DeCaria CM, Nitescu A, Gully R, Suckow RF, Cooper TB, et al. Serotonergic function in obsessive-compulsive disorder: behavioral and neuroendocrine responses to oral m-chlorophenylpiperazine and fenfluramine in patients and healthy volunteers. Arch Gen Psychiatry 1992;49:21.
DOI
ScienceOn
|
67 |
Milanfranchi A, Ravagli S, Lensi P, Marazziti D, Cassano GB. A double- blind study of fluvoxamine and clomipramine in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 1997;12: 131.
DOI
ScienceOn
|
68 |
Zohar J, Chopra M, Sasson Y, Amiaz R, Amital D. Obsessive compulsive disorder: serotonin and beyond. World J Biol Psychiatry 2000;1: 92-100.
DOI
ScienceOn
|
69 |
Yehuda R, Voetb S, Zohara J. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan. Neuropsychobiology 2004;50:200-205.
DOI
ScienceOn
|
70 |
Thoren P, Asberg M, Cronholm B, Jornestedt L, Traskman L. Clomipramine treatment of obsessive-compulsive disorder: I. A controlled clinical trial. Arch Gen Psychiatry 1980;37:1281.
DOI
ScienceOn
|
71 |
Clinical practice guidelines. Management of anxiety disorders. Can J Psychiatry 2006;51:9S-91S.
DOI
|
72 |
Kim SJ, Kim W, Yang JC, Ha TH, Koo MS, Kwon JS, et al. Korean Treatment Algorithm for Obsessive-Compulsive Disorder 2007 (II): Initial Treatment and Treatment Resistant OCD. Korean J Psychopharmacol 2007;18:347-357.
|
73 |
Koran LM, Hanna GL, Hollander E, Nestadt G, Simpson HB. Practice guideline for the treatment of patients with obsessive-compulsive disorder. Am J Psychiatry 2007;164:5-53.
|
74 |
Baxter Jr LR, Phelps ME, Mazziotta JC, Guze BH, Schwartz JM, Selin CE. Local cerebral glucose metabolic rates in obsessive-compulsive disorder: a comparison with rates in unipolar depression and in normal controls. Arch Gen Psychiatry 1987;44:211.
DOI
ScienceOn
|
75 |
American Psychiatric Association, DSM-5 Development http://www.dsm5.org.
|
76 |
Shin YW, Kwon JS, Kim JJ, Kang DH, Youn T, Kang KW, et al. Altered neural circuit for working memory before and after symptom provocation in patients with obsessive-compulsive disorder. Acta Psychiatr Scand 2006;113:420-429.
DOI
ScienceOn
|
77 |
Fontenelle LF, Mendlowicz MV, Versiani M. The descriptive epidemiology of obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:327-337.
DOI
ScienceOn
|
78 |
Ruscio AM, Stein DJ, Chiu WT, Kessler RC. The epidemiology of obsessive- compulsive disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2008;15:53-63.
|
79 |
Burgy M. Psychopathology of obsessive-compulsive disorder: a phenomenological approach. Psychopathology 2005;38:291-300.
DOI
ScienceOn
|
80 |
Lowenfeld L. Die psychischen Zwangserscheinungen; auf klinischer Grundlage dargestellt: Bergmann;1904.
|
81 |
Insel TR. Phenomenology of obsessive compulsive disorder. J Clin Psychiatry 1990;51 Suppl:4-8; discussion 9.
|
82 |
Friedmann M. Zur Auffassung und zur Kenntnis der Zwangsideen und der isolierten uberwertigen Ideen. Zeitschrift fur die gesamte Neurologie und Psychiatrie 1914;21:333-450.
DOI
|
83 |
Friedmann M. Uber die Natur der Zwangsvorstellungen und ihre Beziehungen zum Willensproblem;1920.
|
84 |
Bleuler E, Aschaffenburg G. Dementia praecox: oder Gruppe der Schizophrenien: F. Deuticke;1911.
|
85 |
Marks IM. Review of behavioral psychotherapy, I: Obsessive-compulsive disorders. Am J Psychiatry 1981;138:584.
DOI
|
86 |
Mahony PJ. Freud's cases: are they valuable today? Int J Psychoanal 1993;74:1027-1035.
|
87 |
Frost RO, Steketee G, Tolin D, Glossner K. Diagnostic comorbidity in hoarding and OCD. World Congress of Behavioral and Cognitive Therapies. Boston;2010. p.2-5.
|
88 |
Khanna S, Channabasavanna SM. Towards a classification of compulsions in obsessive compulsive neurosis. Psychopathology 1987;20:23-28.
DOI
ScienceOn
|
89 |
Zohar J, Zohar-Kadouch RC, Kindler S. Current concepts in the pharmacological treatment of obsessive-compulsive disorder. Drugs 1992; 43:210.
DOI
ScienceOn
|
90 |
Leckman JF, Denys D, Simpson HB, Mataix-Cols D, Hollander E, Saxena S, et al. Obsessive-compulsive disorder: a review of the diagnostic criteria and possible subtypes and dimensional specifiers for DSM-V. Depress Anxiety 2010;27:507-527.
DOI
ScienceOn
|
91 |
Saxena S. Neurobiology and treatment of compulsive hoarding. CNS Spectr 2008;13:29.
DOI
|
92 |
Saxena S, Brody AL, Maidment KM, Smith EC, Zohrabi N, Katz E, et al. Cerebral glucose metabolism in obsessive-compulsive hoarding. Am J Psychiatry 2004;161:1038.
DOI
ScienceOn
|
93 |
An S, Mataix-Cols D, Lawrence NS, Wooderson S, Giampietro V, Speckens A, et al. To discard or not to discard: the neural basis of hoarding symptoms in obsessive-compulsive disorder. Mol Psychiatry 2008;14:318-331.
|
94 |
Pallanti S, Hollander E. Obsessive-compulsive disorder spectrum as a scientific "metaphor". CNS Spectr 2008;13:6-15.
|
95 |
Tolin DF, Kiehl KA, Worhunsky P, Book GA, Maltby N. An exploratory study of the neural mechanisms of decision making in compulsive hoarding. Psychol Med 2008;39:325-336.
|
96 |
Samuels J, Shugart YY, Grados MA, Willour VL, Bienvenu OJ, Greenberg BD, et al. Significant linkage to compulsive hoarding on chromosome 14 in families with obsessive-compulsive disorder: results from the OCD Collaborative Genetics Study. Am J Psychiatry 2007; 164:493.
DOI
ScienceOn
|
97 |
Mataix-Cols D, Frost RO, Pertusa A, Clark LA, Saxena S, Leckman JF, et al. Hoarding disorder: a new diagnosis for DSM-V? Depress Anxiety; 2010.
|
98 |
Cath DC, Spinhoven P, Hoogduin C, Landman A, van Woerkom T, van de Wetering B, et al. Repetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences? Psychiatry Res 2001;101:171-185.
DOI
ScienceOn
|
99 |
Peterson BS, Pine DS, Cohen P, Brook JS. Prospective, longitudinal study of tic, obsessive-compulsive, and attention-deficit/hyperactivity disorders in an epidemiological sample. J Am Acad Child Adolesc Psychiatry 2001;40:685-695.
DOI
ScienceOn
|
100 |
Leckman JF, Cohen DJ. Tourette's syndrome: tics, obsessions, compulsions: developmental psychopathology and clinical care: John Wiley & Sons Inc;2001.
|
101 |
Gilbert DL, Kurlan R. PANDAS: Horse or zebra? Neurology 2009; 73:1252.
DOI
ScienceOn
|